- Home
- / Petros Pharmaceuticals
Petros Pharmaceuticals
Stock Price
$0.4
2024-10-29
Market Capitalization
$3.7 M
2024-10-29
Revenue
$5.1 M
FY, 2024
Petros Pharmaceuticals Summary
Company Summary
- Overview
- Petros Pharmaceuticals is a men’s health pharmaceutical company that develops complementary therapeutics solutions. It offers medication adherence and tolerability therapeutics.
- Type
- Public
- Status
- Active
- Founded
- 2020
- HQ
- New York, NY, US | view all locations
- Website
- https://www.petrospharma.com
- Cybersecurity rating
- Sectors
Table of Contents
Key People
Mitchell Arnold, VP, Finance and Chief Accounting Officer
LocationsView all
1 location detected
New York, NY HQ
United States
1185 6th Ave 3rd 570
Petros Pharmaceuticals Financials
Summary Financials
- Net income (Q1, 2026)
- ($987.0K)
- Cash (Q1, 2026)
- $4.4M
- EBIT (Q1, 2026)
- ($1.0M)